Study Design. A case-only study.
A s a structural deformity of the spine, adolescent idiopathic scoliosis (AIS) was reported to affect millions of children worldwide with a prevalence of 2% to 4%. 1, 2 Although most of the AIS patients could have the curve magnitude remaining stable until the skeletal maturity, a small amount of them may have progressive scoliosis that commonly requires brace treatment or even surgical intervention when the curve magnitude eventually exceeds 45 degrees. 3, 4 As progressive scoliosis may lead to cosmetic deformity, back pain, and psychological impairments, there has been an increasing interest in developing predictive methods of curve progression. 5, 6 To date, there is still a poor understanding of the etiology of curve progression in AIS patients. Several clinical risk factors, including gender, chronological age, menarcheal status, Risser sign, and curve pattern, have been reported to be associated with the risk of curve progression. 4, 7 On the basis of these factors, predictive formula was established to determine the probability of curve progression. 4 However, as indicated by the low specificity of the results, the ability of the formula to predict significant progression seems limited and not routinely applicable to clinical practice. Determination of new prognostic factors is therefore warranted to better identify patients with progressive curve.
The role of genetic factors in the etiopathogenesis of AIS has been well documented in previous studies. [8] [9] [10] [11] [12] [13] A combination of genetic markers associated with curve progression has the potential to provide clinically useful prognostic insights. As a powerful tool to study predisposition loci of AIS, genetic association studies have revealed several modifier genes involved in the progression of the curvature, including estrogen receptor 1 (ESR1), 14 matrilin 1 (MATN1), 15 insulin-like growth factor 1 (IGF-1), 16 neurotrophin 3 (NTF3), 8 and tissue inhibitor of metalloproteinase 2 (TIMP2). 17 In recent years, genome-wide association studies (GWAS) further shed light on the etiology of AIS and thus facilitated a more accurate prognostic model on the basis of the multiple genetic markers. [18] [19] [20] Ward et al 21 discovered a panel of 28 progression and 25 protectionassociated markers through GWAS, and developed the first diagnostic kit for curve progression called ''ScoliScore.'' A numeric risk of progression can be calculated by this salivabased genetic test to determine the risk of curve progression requiring surgery in patients with AIS. Patients with low scores (1-50) were found to have more than a 99% probability of not progressing to a severe curve, whereas those with high-risk scores (181-200) could be associated with a 50% to 99% probability of progression. 21 These early results implied that the ScoliScore could provide useful information in various clinical scenarios, probably guiding the optimal treatment for patients with different risk scores.
Although the clinical implications of ScoliScore appear promising, considerations must be taken when applying it to actual practice, as its reliability and validity have not yet been fully confirmed. Ogura et al 22 performed a large-sale replication study in Japanese AIS patients to investigate the relationship between the 53 genetic markers in ScoliScore and curve progression. However, no association on AIS curve progression in any of these single-nucleotide polymorphisms (SNPs) was confirmed in their study, indicating that ScoliScore might not be applicable to predict the curve progression of AIS in Japanese population. Recently, a second replication study of ScoliScore carried out by Tang et al 23 suggested a lack of association between this test and curve progression in AIS patients from French-Canadian population. To our knowledge, there is still a paucity of replication of ScoliScore in China. The primary purpose of this study was to evaluate the associations of the 53 SNPs encompassed in the prognostic test with curve progression in a large cohort of AIS patients from Chinese Han population.
METHODS Subjects
The current case-only study retrospectively reviewed 3526 female scoliosis patients who visited our clinic between May 2004 and December 2014. This study was approved by local Institutional Review Board (Ethical Approval No. njglyy-2014035). Standing posteroanterior radiographs of the whole spine were obtained at each visit and radiographic parameters were recorded, including Cobb angle of the main curve, and Risser sign. Patients were considered to have reached skeletal maturity if having menarche more than 3 years or having a Risser sign of 5. The curve severity was measured by the Cobb method at the latest visit after skeletal maturity for nonoperated patients, or at the last visit before surgery for those being operated on. Specifically, the Cobb angle was measured as the angle formed by the line drawn along the upper endplate of the upper end-vertebrae and lower endplate of the lower end-vertebrae, respectively. 24 Subjects were recruited in this study according to the following inclusion criteria: (1) diagnosed as AIS through clinical and radiological examinations; (2) having no history of brace treatment or any other conservative treatment; (3) either reaching skeletal maturity or undergoing fusion surgery due to curve progression; and (4) with the final curve magnitude being less than 25 degrees or more than 40 degrees.
Genotyping of the Target SNP
Blood sample for DNA extraction was collected from each patient with informed consent obtained. Genomic DNA was extracted under standard protocols (Qiagen K.K., Tokyo, Japan). A total of 53 SNPs reported as the genetic markers of the ScoliScore were genotyped using TaqMan SNP Genotyping Assay, which was read with an ABI PRISM 7900HT sequence detection system (Applied Biosystems, Foster City, CA) as previously described. 25 Twenty percent of the samples were selected randomly to validate the reliability of the genotyping results.
Statistical Analysis
The Hardy-Weinberg equilibrium (HWE) test was used for all patients. Patients with Cobb angle less than 25 degrees at the final follow-up were assigned to nonprogression group, and those with Cobb angle more than 40 degrees were assigned to progression group accordingly. The differences of allele distributions between nonprogression group and progression group were compared using the Chi-square test. Odds ratio (OR) was calculated using the minor allele as a reference. The SPSS software (version 16.0; SPSS Inc., Chicago, IL) was used for statistical analyses. Statistical significance was set at a P value of less than 0.05.
RESULTS
Overall, a total of 670 patients were included in the study, with 313 patients assigned to the nonprogression group and the other 357 patients assigned to the progression group. The 2 groups were matched in terms of age at the initial visit (12.3 AE 2.5 vs 12.5 AE 2.7 years, P ¼ 0.32). The Cobb angle was averaged 22.6 AE 3.7 degrees for nonprogression group and 53.4 AE 12.7 degrees for progression group. All the 53 SNPs were successfully genotyped for both groups. No significant difference of genotype frequencies was noted from the HWE test.
The minor allele frequency (MAF) values of the whole 53 SNPs were summarized in Table 1 . Four SNPs were found to have MAF below 1%, including rs7613792, rs16902899, rs10787096, and rs6798946. Besides, the previously reported polymorphisms of rs2700910, rs1558729, and rs17635546 were not recognized in the subjects. As summarized in Table 1 , rs9945359 and rs17044552 are the only 2 SNPs that had significantly different allele frequencies between the 2 groups. Allele A of rs9945359 was significantly higher in the progression group than in the nonprogression group (25.7% vs 19.5%, P ¼ 0.01), and allele A of rs17044552 was significantly lower in the progression group (11.5% vs 16.4%, P ¼ 0.01 for rs17044552). The ORs of these 2 SNPs were 1.42 (95% CI 1.09-1.88) and 0.65 (95% CI 0.47-0.91), respectively. As for the allele frequency of the other 51 SNPs, no significant difference was found between the 2 groups. After comparing the OR value of each SNP with those reported by Ward et al, 21 we observed that 30 SNPs showed reverse trends concerning its risk or protective role in the curve progression (Table 1) .
DISCUSSION
Although much progress concerning the genetic markers related to curve progression of AIS has been made, spurious association may be produced along with these intriguing findings. As there exists a significant divergence among different populations regarding the association of modifier genes with the curve progression of AIS, 22, 23, 26 replication study is warranted for the validation of readily reported findings, which could be helpful to expand our understanding of the genetic architecture of AIS. In the current study, the diagnostic kit ScoliScore was replicated in Chinese population for the first time. Most of the 53 SNPs encompassed in ScoliScore were found not to be associated with the curve severity of AIS, although they all showed a significant association with curve progression in the whites. 21 Thirty SNPs were observed to have reverse trends concerning their risky or protective roles in the curve progression as compared with those reported in the white population. 21 Collectively, these findings suggested that ScoliScore could have a limited predictability for the progressive curve of AIS patients in Chinese population.
Before the current study, 3 independent studies had been performed to investigate the validity of ScoliScore in predicting the risk of curve progression. 22, 23, 27 Roye et al 27 compared risk stratification of ScoliScore with commonly used clinical risk markers to determine the test's clinical utility. They found that the 2 methods differed greatly in predicting the risk of progressive curve, suggesting that continued efforts were needed to justify the application of this test. 27 Tang et al 23 analyzed the association of SNPs used in ScoliScore with curve progression on the basis of genomic data collected from the French-Canadian population. They found no significant difference between the severe group and the nonsevere group or between the severe group and the control group regarding the risk allele frequencies of these SNPs. 23 Ogura et al 22 genotyped the 53 genetic markers used in the test and compared their distributions between patients with progressive curve and those with nonprogressive curve. Comparable with the findings of our study, Ogura et al 22 found that none of the genotyped SNPs was associated with the curve progression in Japanese population. In addition, 6 SNPs were found to have MAF less than 1%, including rs7613792, rs16902899, rs2700910, rs10787096, rs1558729, and rs17635546. 22 Three other SNPs failed to be recognized in their subjects, including rs2700910, rs1558729, and rs17635546. 22 Similarly, in the current study, we found that 4 SNPs have MAF less than 1%, and there was a lack of polymorphisms of 3 SNPs that were exactly the same as those reported by Ogura et al. 22 Putting all these findings together, it was obvious that ethnic differences between Asian population and the white population could yield great divergence regarding the diagnostic power of ScoliScore.
Two SNPs, including rs9945359 and rs17044552, were confirmed in our study to be associated with curve severity. The OR values of these 2 SNPs were 1.72 and 0.65, respectively, seemingly in line with the value of 1.28 and 0.54 as reported by Ward et al. 21 Despite of the existing ethnic differences, AIS patients could share these 2 SNPs as common traits in the pathogenesis of curve progression. rs9945359 is located in about 200 kb downstream of SETBP1 gene that encodes SET-binding protein 1, a binding partner for the multi-function SET protein. 28 Initial identification of germline SETBP1 alterations affecting amino acid residues between 858 and 871 has been described in patients with Schinzel-Giedion syndrome, associated with a congenital phenotype including mental retardation and facial deformities. 29 rs17044552 was located in about 400 kb downstream of KLHL29 gene, 1 member of the KLHL gene family that are responsible for several Mendelian diseases. 30 Further investigation of these 2 genes will likely provide valuable insights into the relationship between gene function and curve progression. 
